$67.91 0.2%
AXNX Stock Price vs. AI Score (Last 150 days)
Data gathered: July 15

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

About Axonics

Axonics, Inc., a medical technology company, engages in the development and commercialization of novel products for the treatment of bladder and bowel dysfunction.

Price $67.91
Target Price Sign up
Volume 50,280
Market Cap $3.46B
Year Range $50.41 - $69.65
Dividend Yield 0%
Revenue per Employee $748,814
Industry Medical Devices

In the news

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q1 '2491M100M69M-19M-17M
Q4 '23110M99M83M6.6M3.3M0.130
Q3 '2393M86M69M3.9M1.6M0.080
Q2 '2393M81M70M-7.3M-9.8M0.160
Q1 '2371M78M53M-9.2M-12M-0.190

Insider Transactions View All

Keese Kari Leigh filed to sell 43,323 shares at $67.7.
February 2 '24
COHEN RAYMOND W filed to sell 188,835 shares at $67.7.
February 2 '24
Ford Alfred J Jr filed to sell 43,450 shares at $67.7.
February 2 '24
Woock John filed to sell 77,403 shares at $67.7.
February 2 '24
Noblett Karen filed to sell 34,428 shares at $67.7.
February 2 '24

What is the Market Cap of Axonics?

The Market Cap of Axonics is $3.46B.

How Many People Work at Axonics?

As of our latest update, Axonics employed approximately 517 people worldwide. However, it's important to note that Axonics' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.

What is Axonics' revenue per employee?

$748,814. To calculate Axonics' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.

What is the current stock price of Axonics?

Currently, the price of one share of Axonics stock is $67.91.

How can I analyze the AXNX stock price chart for investment decisions?

The AXNX stock price chart above provides a comprehensive visual representation of Axonics' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Axonics shares. Our platform offers an up-to-date AXNX stock price chart, along with technical data analysis and alternative data insights.

Does AXNX offer dividends to its shareholders?

As of our latest update, Axonics (AXNX) does not offer dividends to its shareholders. Investors interested in Axonics should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.

What are some of the similar stocks of Axonics?

Some of the similar stocks of Axonics are Boston Scientific, Edwards Lifesciences, Intuitive Surgical, Medtronic, and Stryker.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.